Batsheva Kerem

Prof. Batsheva Kerem is a Principal Investigator at the Hebrew University of Jerusalem, leading a research group focused on Cancer Research and Personalized Medicine approaches for Cystic Fibrosis (CF). Her work addresses genomic instability in tumorigenesis and develops therapies for CF patients with rare mutations using patient-derived organoids.

Research Interests:

• Cancer Research: Investigating genomic instability mechanisms, DNA replication stress, transcription, and chromatin remodeling in cancer development.
• Personalized Medicine: Targeting CF via organoid models to address rare CFTR gene mutations and improve treatment for Caucasians with this lethal genetic disease.

Advising & Team:

• PhD Students: Tchelet Goldberg (MD PhD), Wisam Zaatra, Reem Aldwaik
• MSc Student: Omer Setty
• Lab Manager: Dr. Michal Irony-Tur
• Bioinformatics: Dr. Shira Milo

Labs & Collaborations: The Kerem Lab integrates genomic, biochemical, and clinical approaches to bridge basic cancer research and CF therapeutic innovation. Collaborations focus on translational medicine and rare disease solutions.